Abstract:Background:With the advancement of early detection and treatment, the incidence of colon cancer (CC) has declined steadily worldwide; however, the mortality remains unacceptably high. Tripartite motif 52 (TRIM52) is a member of the family of highly conserved RBCC (a RING-finger, two B-boxes, and a predicted alpha-helical Coiled-Coil domain were linked to the N-terminal region in sequence) proteins with more than 70 isoforms, which plays an important role in tumorigenesis through different signaling pathways. How it regulates the development of CC remains unknown.Methods:Western blot was used to reveal that TRIM52 protein expression is up-regulated in CC cells. The Analysis of The Cancer Genome Atlas (TCGA) database was used to find the different expressions of TRIM52 between colon cancer tissues and normal colonic epithelial tissues. Cell proliferation assays, migration and invasion assays, and apoptosis were used to verify the changes in cell function after knockdown or overexpression of TRIM52 in CC cells. After that, the key proteins of the nuclear factor (NF)-κB signaling pathway were validated by western blot to explore the role of TRIM52 in the NF-κB signaling pathway. Finally, in order to explore the potential sites of TRIM52, LPS and PDTC were employed to activate and block the NF-κB signaling pathway, and the key proteins of the NF-κB signaling pathway were validated by western blot.Results:TGCA database revealed that TRIM52 expression was elevated in CC tissues and correlated with prognosis. It was verified that TRIM52 promoted the proliferation, migration, and invasion of CC cells, and inhibited cell apoptosis. Most of the tripartite motif proteins (TRIMs) have ubiquitin ligase activity related to their highly conserved RING structure. Detection of the key proteins of the NF-κB signaling pathway in CC cells revealed that TRIM52 activated the NF-κB signaling pathway.Conclusions:We confirmed that TRIM52 promotes proliferation, migration, and invasion while inhibiting apoptosis of CC cells. The regulatory effect of TRIM52 on CC cells is related to the activation of the NF-κB signaling pathway. As TRIM52 acted as an upstream stimulator, stimulating the transfer of P65 into the nucleus to activate the NF-κB signaling pathway, it may provide a potential target for prognosis prediction and treatment of CC.

Human tripartite motif protein 52 is required for cell context-dependent proliferation

TRIM52 is a primate-specific player in the DNA repair process under tight proteolytic control by a triad of giant E3 ligases

Tripartite Motif 52 (TRIM52) Promotes Proliferation, Migration, and Regulation of Colon Cancer Cells Associated with the NF-κB Signaling Pathway.

TRIM56 Promotes Malignant Progression of Glioblastoma by Stabilizing Ciap1 Protein.

Trim65 Negatively Regulates P53 Through Ubiquitination

TRIM family contribute to tumorigenesis, cancer development, and drug resistance

Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers

TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A

TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway

TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins

Role of Tripartite Motif Protein 27 As a Gametogenesis-Related Protein in Human Germ Cells.

Tumor suppressor p53 cross-talks with TRIM family proteins

Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter

TRIM21 Overexpression Promotes Tumor Progression by Regulating Cell Proliferation, Cell Migration and Cell Senescence in Human Glioma.

The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer

TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis

TRIM11 Promotes Proliferation and Glycolysis of Breast Cancer Cells Via Targeting AKT/GLUT1 Pathway

TRIM44 is Indispensable for Glioma Cell Proliferation and Cell Cycle Progression Through AKT/p21/p27 Signaling Pathway.

Combinatory Inhibition of TRIM65 and MDM2 in Lung Cancer Cells

Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis

TRIM31: A Molecule with a Dual Role in Cancer